InViVo
-
Spine
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes
By Laura Dyrda The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold. Here are five key…
Read More » -
Financial
InVivo’s Q2 net loss hits $10.4M as spinal cord injury trial shows early success: 5 things to know
By Laura Dyrda InVivo Therapeutics reported $10.4 million net loss in the second quarter of 2015. However, CEO Mark Perrin is focused…
Read More » -
Recon
LDR, MEDTECH, Paradigm Spine & more — 14 key notes
By Anuja Vaidya Here are 14 key notes on spine and orthopedic device companies this week. Bioventus named a new vice…
Read More » -
Neuro
New hope for spinal cord injuries; AZ man sees progress after rare surgery
By Ty Brennan A Peoria man was the first person in the world to undergo a revolutionary type of surgery.…
Read More » -
Financial
InVivo Therapeutics Appoints Steven McAllister as CFO
CAMBRIDGE, Mass. (June 19, 2014) – InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Steven McAllister as Chief Financial…
Read More » -
InVivo stock plunges as acting CFO resigns
Stock in InVivo Therapeutics Holdings Corp. (OTC: NVIV) plunged as much as 22 percent after the company announced the resignation of its…
Read More » -
InVivo Tanks After Pushing Back Spinal Study
InVivo Therapeutics planned to kick off a study of its investigational spinal implant in the coming months, but an FDA…
Read More » -
InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist
CAMBRIDGE, Mass., Dec 12, 2011 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (otc/bb:NVIV), a company focused on the development of…
Read More » -
InVivo exceeds private placement by $2.5M
InVivo Therapeutics today said that its previously announced $10.5 million private placement actually brought in $13 milion with additional units…
Read More » -
InVivo Therapeutics opens Medford facility
InVivo Therapeutics Corp., a life sciences company developing technologies for the treatment of spinal cord injuries, has signed a lease…
Read More » -
George Nolen, Recently Retired CEO of Siemens Corporation, Joins InVivo Therapeutics Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Corporation has added George Nolen, former President and Chief Executive Officer of Siemens Corporation, to its…
Read More »